Therapy in Patients with Chronic Myeloid Leukemia Outside of Clinical Trials: Results of the German CML-Registry (CML-VI)

被引:0
|
作者
Kohlbrenner, Katharina [1 ]
Galuschek, Norbert [1 ]
Fabarius, Alice [1 ]
Reiser, Marcel
Fenchel, Klaus [2 ]
Esseling, Eva [3 ]
Goehler, Thomas [4 ]
Geer, Thomas [5 ]
Depenbusch, Reinhard [6 ]
Azeh, Ivo Talah [7 ]
Engel, Erik [8 ]
Hansen, Richard [9 ]
Lindemann, Hans-Walter [10 ]
Anhuf, Juergen [11 ]
Jehner, Paul [12 ]
Abu-Samra, Maisun [13 ]
Ritter, Markus [14 ]
Gattermann, Norbert [15 ]
Pelz, Henning [16 ]
Fuxius, Stefan [17 ]
Oswald, Burkhard [18 ]
Baerlocher, Gabriela M. [19 ,20 ]
Brummendorf, Tim H. H. [21 ]
Heim, Dominik [22 ]
le Coutre, Philipp [23 ]
Burchert, Andreas [24 ]
Niederwieser, Dietger [25 ]
Tesch, Hans [26 ]
Hofmann, Wolf-Karsten [1 ]
Hochhaus, Andreas [27 ]
Hehlmann, Ruediger [28 ]
Saussele, Susanne [1 ]
机构
[1] Heidelberg Univ, Med Fak Mannheim, Med Klin 3, Mannheim, Germany
[2] Onkol Praxisklin Hamatol Onkol & Gerinnungsstorun, Saalfeld, Germany
[3] Univ Klinikum Munster, Med Klin A, Munster, Germany
[4] Onkozentrum Dresden, Dresden, Germany
[5] Diakonie Klinikum, Innere Med 3, Schwabisch Hall, Germany
[6] Onkol Gemeinschaftspraxis Dres Depenbusch, Schutt and Sonnenberg, Gutersloh, Germany
[7] Onkol Gemeinschaftspraxis & Tagesklin Dres Med C, Gelsenkirchen, Germany
[8] Hamatol Onkol Praxis Altona HOPA, Hamburg, Germany
[9] Onkol Gemeinschaftspraxis Dres Hansen & Reeb, Kaiserslautern, Germany
[10] Katholisches Krankenhaus, Hamatol & Onkol, Hagen, Germany
[11] Onkol Duisburg Nord, Duisburg, Germany
[12] Onkol Praxis Moers, Moers, Germany
[13] Univ Klinikum Giessen & Marburg, Med Klin & Poliklin Hamatol 4, Giessen, Germany
[14] MVZ Sindelfingen, Onkol Praxis, Sindelfingen, Germany
[15] Univ Klinikum Dusseldorf, Klin Hamatol Onkol & Klin Immunol, Dusseldorf, Germany
[16] Ambulantes Therapiezentrum Hamatol & Onkol, Offenburg, Germany
[17] Onkol Schwerpunktpraxis Heidelberg, Heidelberg, Germany
[18] Onkol Schwerpunktpraxis Worms, Worms, Germany
[19] Univ Klin Hamatol, Inselspital Bern, Bern, Switzerland
[20] Univ Bern, Dept BioMed Res DBMR, Bern, Switzerland
[21] Univ Klinikum RWTH Aachen, Med Klin 4, Aachen, Germany
[22] Univ Spital Basel, Klin Hamatol, Basel, Switzerland
[23] Charite Univ Med Berlin, Campus Virchow Med Klin S Hamatol & Onkol, Berlin, Germany
[24] Univ Klinikum Giessen & Marburg, Hamatol Onkol & Immunol, Marburg, Germany
[25] Univ Klinikum Leipzig, Abt Hamatol & Internist Onkol, Leipzig, Germany
[26] Ctr Hamatol & Onkol Bethanien, Frankfurt, Germany
[27] Univ Klinikum Jena, Abt Hamatol & Internist Onkol, Klin Innere Med 2, Jena, Germany
[28] Heidelberg Univ, Med Fak Mannheim, Mannheim, Germany
关键词
D O I
10.1182/blood-2022-159412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Discontinuation of tyrosine kinase inhibitor therapy in CML patients outside of clinical trials: Interim results of the German CML VI trial
    Kohlbrenner, K.
    Galuschek, N.
    Fabarius, A.
    Reiser, M.
    Fenchel, K.
    Esseling, E.
    Gohler, T.
    Kuhn, R. B.
    Depenbusch, R.
    Azeh, I
    Engel, E.
    Hansen, R.
    Haenel, M.
    Anhuf, J.
    Jehner, P.
    Abu Samra, M.
    Ritter, M.
    Gattermann, N.
    Pelz, H.
    Fuxius, S.
    Oswald, B.
    Baerlocher, G. M.
    Bruemmendorf, T. H.
    Heim, D.
    le Coutre, P.
    Burchert, A.
    Niederwieser, D.
    Tesch, H.
    Hofmann, W. -K
    Hochhaus, A.
    Hehlmann, R.
    Saussele, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 68 - 69
  • [2] High age and high frequency of treatment switch in CML patients outside of clinical trials: interim results of the German CML VI trial
    Kohlbrenner, K.
    Arnecke, L.
    Fabarius, A.
    Bieber, R.
    Voskanyan, A.
    Reiser, M.
    Fenchel, K.
    Schmidt, E.
    Goehler, T.
    Kuehn, R. B.
    Depenbusch, R.
    Azeh, I.
    Kleeberg, U. R.
    Hansen, R.
    Haenel, M.
    Anhuf, J.
    Jehner, P.
    Baerlocher, G. M.
    Bruemmendorf, T. H.
    Ehninger, G.
    Hasford, J.
    Heim, D.
    Hossfeld, D. K.
    Kolb, H. -J.
    Krause, S. W.
    le Coutre, P.
    Nerl, C.
    Neubauer, A.
    Niederwieser, D.
    Tesch, H.
    Hochhaus, A.
    Hehlmann, R.
    Saussele, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 145 - 145
  • [3] Outcome and Prognosis of 1955 Patients with Chronic Myeloid Leukemia: First Results of the CML-Registry of the European Treatment and Outcome Study EUTOS.
    Hasford, Joerg
    Rosti, Gianantonio
    Lindoerfer, Doris
    Baccarani, Michele
    Guilhot, Joelle
    Montrucchio, Lara
    Rancati, Francesca
    Simonsson, Bengt
    Nicolini, Franck Emmanuel
    Ossenkoppele, Gert
    Hehlmann, Ruediger
    BLOOD, 2009, 114 (22) : 455 - 455
  • [4] REAL WORLD DATA ON CHRONIC MYELOID LEUKEMIA - A REPORT FROM THE SWEDISH POPULATION BASED CML-REGISTRY
    Hoglund, M.
    Bjoreman, M.
    Bjorkholm, M.
    Brune, M.
    Ekblom, M.
    Hellstrom, K.
    Lehmann, S.
    Ljungman, P.
    Malm, C.
    Markevarn, B.
    Sandin, F.
    Stenke, L.
    Wadenvik, H.
    Wahlin, A.
    Richter, J.
    Simonsson, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 337 - 338
  • [5] FRONTLINE THERAPY OF CHRONIC MYELOID LEUKEMIA (CML)
    Kantarjian, Hagop
    LEUKEMIA RESEARCH, 2014, 38 : S1 - S1
  • [6] THE NEW EUTOS SCORE HAS PROGNOSTIC VALUE IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) OUTSIDE CLINICAL TRIALS
    Casado Montero, L. F.
    Garcia-Gutierrez, V.
    Maestro, B.
    Massague, I.
    Giraldo, P.
    Perez-Encinas, M.
    De Paz, R.
    Martinez-Lopez, J.
    Bautista, G.
    Osorio, S.
    Requena, M. J.
    Palomera, L.
    Penarrubia, M. J.
    Dumas, M. H.
    Garcia-Ormena, N.
    Calle, C.
    Hernandez-Rivas, J. A.
    Steegmann, J. L.
    HAEMATOLOGICA, 2012, 97 : 310 - 310
  • [7] Phase II Clinical Trial Results of Dasatinib for Frontline Therapy in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)
    Pemmaraju, Naveen
    Kantarjian, Hagop M.
    O'Brien, Susan
    Borthakur, Gautam
    Ravandi, Farhad
    Verstovsek, Srdan
    Daver, Naval G.
    Garcia-Manero, Guillermo
    DiNardo, Courtney D.
    Skinner, Jeff
    Konopleva, Marina
    Pierce, Sherry
    Jabbour, Elias
    Cortes, Jorge E.
    BLOOD, 2014, 124 (21)
  • [8] The International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped-Study): Objectives and Preliminary Results
    Millot, Frederic
    Suttorp, Meinolf
    Guilhot, Joelle
    Sedlacek, Pietr
    De Bont, Evelina S.
    Li, Chi Kong
    Kalwak, Krzysztof
    Lausen, Birgitte
    Srdjana, Culic
    Dresse, Marie-Francoise
    Biondi, Andrea
    Baruchel, Andre
    BLOOD, 2012, 120 (21)
  • [9] SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS
    Enrico, A.
    Pavlovsky, C.
    Mariano, R.
    Moiraghi, B.
    Bendek, G.
    Milone, J.
    HAEMATOLOGICA, 2013, 98 : 551 - 551
  • [10] Chronic myeloid leukemia (CML) in childhood - Results of the multicenter-trial CML-paed
    Suttorp, M
    Claviez, A
    Martiniak, Y
    Klingebiel, T
    Niethammer, D
    Gadner, H
    Peters, C
    Kabisch, H
    Kremens, B
    Zintl, F
    Henze, G
    Goebel, U
    BLOOD, 2004, 104 (11) : 178A - 179A